Publication: Antiparasitic Activity of Bromotyrosine Alkaloids and New Analogues Isolated from the Fijian Marine Sponge Aplysinella rhax.
dc.contributor.author | Oluwabusola, Emmanuel T | |
dc.contributor.author | Tabudravu, Jioji N | |
dc.contributor.author | Al Maqbali, Khalid S | |
dc.contributor.author | Annang, Frederick | |
dc.contributor.author | Pérez-Moreno, Guiomar | |
dc.contributor.author | Reyes, Fernando | |
dc.contributor.author | Jaspars, Marcel | |
dc.date.accessioned | 2023-02-09T09:37:11Z | |
dc.date.available | 2023-02-09T09:37:11Z | |
dc.date.issued | 2020-09-29 | |
dc.description.abstract | Ten bromotyrosine alkaloids were isolated and characterised from the marine sponge Aplysinella rhax (de Laubenfels 1954) collected from the Fiji Islands, which included one new bromotyrosine analogue, psammaplin P and two other analogues, psammaplin O and 3-bromo-2-hydroxy-5-(methoxycarbonyl)benzoic acid, which have not been previously reported from natural sources. HR-ESI-MS, 1D and 2D NMR spectroscopic methods were used in the elucidation of the compounds. Bisaprasin, a biphenylic dimer of psammaplin A, showed moderate activity with IC50 at 19±5 and 29±6 μM against Trypanzoma cruzi Tulahuen C4, and the lethal human malaria species Plasmodium falciparum clone 3D7, respectively, while psammaplins A and D exhibited low activity against both parasites. This is the first report of the antimalarial and antitrypanosomal activity of the psammaplin-type compounds. Additionally, the biosynthesis hypotheses of three natural products were proposed. | |
dc.identifier.doi | 10.1002/cbdv.202000335 | |
dc.identifier.essn | 1612-1880 | |
dc.identifier.pmid | 32697400 | |
dc.identifier.unpaywallURL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cbdv.202000335 | |
dc.identifier.uri | http://hdl.handle.net/10668/15974 | |
dc.issue.number | 10 | |
dc.journal.title | Chemistry & biodiversity | |
dc.journal.titleabbreviation | Chem Biodivers | |
dc.language.iso | en | |
dc.organization | Fundación MEDINA (Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía) | |
dc.organization | Fundación MEDINA | |
dc.page.number | e2000335 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Chagas disease | |
dc.subject | bromotyrosine | |
dc.subject | malaria | |
dc.subject | psammaplin | |
dc.subject | sponge | |
dc.subject.mesh | Alkaloids | |
dc.subject.mesh | Animals | |
dc.subject.mesh | Antiprotozoal Agents | |
dc.subject.mesh | Biological Products | |
dc.subject.mesh | Molecular Structure | |
dc.subject.mesh | Parasitic Sensitivity Tests | |
dc.subject.mesh | Plasmodium falciparum | |
dc.subject.mesh | Porifera | |
dc.subject.mesh | Trypanosoma cruzi | |
dc.subject.mesh | Tyrosine | |
dc.title | Antiparasitic Activity of Bromotyrosine Alkaloids and New Analogues Isolated from the Fijian Marine Sponge Aplysinella rhax. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 17 | |
dspace.entity.type | Publication |